1. Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores

   Broekman, K. E., Jalving, M., van Tinteren, H., Sessa, C. & Reyners, A. K. L., Sep-2018, In : CANCER TREATMENT REVIEWS. 69, p. 233-242 10 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. The Dutch national guideline on metastases and hematological malignancies localized within the spine; a multidisciplinary collaboration towards timely and proactive management

   Groenen, K. H. J., van der Linden, Y. M., Brouwer, T., Dijkstra, S. P. D., de Graeff, A., Algra, P. R., Kuijlen, J. M. A., Minnema, M. C., Nijboer, C., Poelma, D. L. H., Rolf, C., Sluis, T., Terheggen, M. A. M. B., van der Togt-van Leeuwen, A. C. M., Bartels, R. H. M. A. & Taal, W., Sep-2018, In : CANCER TREATMENT REVIEWS. 69, p. 29-38 10 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

3. Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

   Qiu, S-Q., Waaijer, S. J. H., Zwager, M. C., de Vries, E. G. E., van der Vegt, B. & Schroeder, C. P., Nov-2018, In : CANCER TREATMENT REVIEWS. 70, p. 178-189 12 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. Molecular imaging to enlighten cancer immunotherapies and underlying involved processes

   van der Veen, E. L., Bensch, F., Glaudemans, A. W. J. M., Lub-de Hooge, M. N. & de Vries, E. G. E., Nov-2018, In : CANCER TREATMENT REVIEWS. 70, p. 232-244 13 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer

   Bense, R. D., Qiu, S-Q., de Vries, E. G. E., Schröder, C. P. & Fehrmann, R. S. N., Nov-2018, In : CANCER TREATMENT REVIEWS. 70, p. 118-126 9 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

View all (48) »